4,6-Dichloro-2-Methylpyrimidine CAS 1780-26-3 Maʻemaʻe ≥99.5% (GC) hale kūʻai wela
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Inoa Kimia | 4,6-Dichloro-2-Methylpyrimidine |
Nā huaʻōlelo like | 2-Methyl-4,6-Dichloropyrimidine;2,4-Dichloro-6-Methylpyrimidine |
Helu CAS | 1780-26-3 |
Helu CAT | RF-PI687 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona |
ʻĀpana Molekala | C5H4Cl2N2 |
Kaumaha Molecular | 163.00 |
Lae hehee | 41.5~45.5℃ (māmā) |
Solubility (Soluble in) | Methanol |
Brand | ʻO Ruifu Chemical |
'ikamu | Nā kikoʻī |
Ka nana aku | Keʻokeʻo a i ʻole ke keʻokeʻo Crystalline pauda |
Maʻemaʻe / Kaʻina Hanana | ≥99.5% (GC) |
Nalo ma ka maloo | ≤0.50% |
Koena ma ka Ignition | ≤0.20% |
Hoʻokahi haumia | ≤0.50% |
Huina paumaele | ≤0.50% |
Kūlana hoʻāʻo | ʻOihana Kūlana |
Hoʻohana | Lapaʻau Kūwaena;ʻO Dasatinib / Moxonidine Intermediate |
4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) Alanui Kaʻina
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
Hoʻohana ʻia ʻo 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) i ka synthesis o nā intermediates pharmaceutical a me nā API.Nā Huahana Hoʻomākaukau: Moxonidine (CAS: 75438-57-2);Dasatinib (CAS: 302962-49-8);Dasatinib Monohydrate (CAS: 863127-77-9);4-Chloro-2,6-Dimethylpyrimidine (CAS: 4472-45-1);4-Amino-6-Chloro-2-Methylpyrimidine (CAS: 1749-68-4).He ʻano lāʻau antihypertensive hou ʻo Moxonidine, i hoʻohana mau ʻia i ka mālama ʻana i ka hypertension koʻikoʻi.Ke hoʻohālikelike ʻia me nā antihypertensives hana waena kahiko, hoʻopaʻa ʻia ʻo Moxonidine me ka pili nui loa i ka imidazoline I1-receptor ma mua o ka α2-receptor.Dasatinib mea he waha potent oncogenic kinase inhibitor, hiki ke ālai i ka hōʻailona o ka maʻi 'aʻai keena replication acceleration , i Mei 2009, ka US Food a me Drug Administration (FDA) formally apono i ke kuai ana o dasatinib , Ua hoʻohana 'ia no ka mālama 'ana i nā ma'i like 'ole. leukemia myeloid (CML), me ka mālama ʻana i ka maʻi leukemia myeloid maʻi ʻaʻole i ʻae ʻia i nā papahana lapaʻau e like me ka imatinib mesylate., Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) a me ka mālama ʻana i nā maʻi me nā maʻi koko paʻa.